Skip to main content
PMC home page
Springer logoLink to Springer
. 2021 Jul 20;22(6):205. doi: 10.1208/s12249-021-02081-z

Preparation and Characterization of Electrospun Polylactic Acid (PLA) Fiber Loaded with Birch Bark Triterpene Extract for Wound Dressing

Tianyuan Fan 1,2, Rolf Daniels 3,✉
PMCID: PMC8292269  PMID: 34286391

Abstract

Drug-loaded electrospun fibers have attracted increasing attention as a promising wound dressing material due to their capability of preventing from infections and inflammation and maintaining an appropriate environment for wound healing. In this study, polylactic acid (PLA), which is widely used in wound management, was chosen as electrospinnable polymer. A triterpene extract (TE) from the outer bark of birch known for its anti-inflammatory, antiviral, antibacterial, and wound healing effects was chosen to produce TE-loaded PLA electrospun fibers for wound dressing. A binary solvent system of dichloromethane (DCM) and dimethyl sulfoxide (DMSO) was employed, and the ratio of the solvents was optimized for preparing smooth and uniform fibers. The morphology of TE-loaded PLA electrospun fibers was investigated by scanning electron microscopy (SEM). The entrapment of TE in PLA fibers was confirmed by confocal laser scanning microscopy (CLSM). Differential scanning calorimetry (DSC) and X-ray diffraction (XRD) were used to analyze the solid state of TE in PLA fibers. The release behavior of TE was assayed by a shaking flask method for a period of 96 h. The results revealed that TE-loaded electrospun PLA microfibers could be reliably prepared and are promising future candidates in wound therapy.

KEY WORDS: electrospinning;, polylactic acid;, triterpene extract;, wound dressing;, drug release

INTRODUCTION

Electrospinning technology has attracted much attention for wound healing in recent years due to its simplicity, reproducibility, and cost-efficacy (1). In a typical electrospinning process, a high-voltage electric field is applied between the polymeric solution and a metallic collector which act as a counter electrode. Due to electrostatic attraction, a nano- or microfiber is formed through liquid jetting. The solvents from the polymer solution evaporate during the travel in the electrical field and a solid fiber reaches the collector (1). Electrospun fiber-based dressings not only maintain wound hydration, absorb excess wound exudate, minimize wound trauma, and barrier external microorganisms in traditional way, but also mimic the native dermal extracellular matrix (ECM) and have high surface area-to-volume ratio as well as high porosity, which tends to create positive environment to reduce infection and inflammation and to promote wound healing (2). Besides, electrospun fibrous membranes can act as drug delivery systems by loading therapeutic agents including antimicrobial, anti-inflammatory, and antioxidant species to prevent skin infections and improve wound healing process (3,4).

Polylactic acid (PLA) is so far the most extensively researched and utilized biodegradable aliphatic polyester in human history. It plays an increasingly important role in medical applications owing to its unique properties comprising biodegradability, biocompatibility, and complete reabsorbability. PLA has been used in a wide range of applications related to wound management, such as surgical sutures, healing dental extraction wounds, and preventing postoperative adhesions (5,6). PLA appears as L-PLA (PLLA), D-PLA (PDLA), racemic mixture D, L-PLA (PDLLA), and stereocomplex PLA (sc-PLA) (7,8). All the four kinds of PLA can be used to prepare electrospun fibers (9). Electrospun PLA fibers have been reported to have positive effect on collagen deposition, angiogenesis, and inflammation, and accelerate the rate of wound closure compared to commercial gauzes (10). In another report, electrospun PLA scaffolds with minced skin grafts together have been used as skin substitute for surgical repair of skin defects in plastic and reconstructive surgery. The skin cells were confirmed to migrate along the PLA fibers of the scaffold and new collagen was formed (11). Drug-loaded electrospun PLA fibers have also been reported to enhance wound healing in literature. Cyclosporine A-loaded electrospun PLA nanofibers effectively suppressed inflammation and neovascularization compared with drug-free PLA nanofibers in the treatment of alkali-injured rabbit cornea (12). Aligned porous electrospun PLA fibrous membranes containing dimethyloxalylglycine-loaded mesoporous silica nanoparticles were demonstrated to simulate the healing of diabetic wound in vitro (13). Nitrofurazone-loaded electrospun PLA/sericin-based dual-layer fiber mats performed better in decreasing wound size in rats than commercial non-woven dressing did (14). An electrospun PLA scaffold integrating nucleic acid delivery produced significant enhancements in wound healing in mice (15).

Triterpene extract (TE) from the outer bark of birch consisting of betulin, betulinic acid, lupeol, erythrodiol, caffeoyl-betulin, and oleanolic acid shows anti-inflammatory, antiviral, antimicrobial, and other pharmacological activities (16–18). TE and betulin were reported to address the inflammatory phase of wound healing by transient upregulation of several pro-inflammatory mediators and enhance the migration of keratinocytes in the second phase of wound healing (19). TE-based oleogel (Episalvan) can affect all the three phases of wound healing, including inflammation, migration, and differentiation, and promote wound healing in several clinical phase II and phase III studies. It was approved by the European Medicine Agency (EMA) for the European Economic Area in 2016 to accelerate wound closure in partial thickness wounds, which opened up the area of application of wound healing for phytotherapy in plastic surgery and especially in burn medicine (18,20).

Combining the advantages of electrospinning fibers and the pharmacological activities of TE for wound healing, TE-loaded PLA electrospun fibers were fabricated for wound dressing in this study. The electrospun fibers were then characterized in vitro by scanning electron microscopy (SEM), confocal laser scanning microscopy (CLSM), differential scanning calorimetry (DSC), and X-ray diffraction (XRD). The drug release behavior was also investigated. The methods used and results obtained in this study were discussed carefully by searching and comparing with a number of related literatures.

MATERIALS AND METHODS

Materials

Polylactic acid (PLA L207S) was purchased from Evonik, Germany. A pharmaceutical grade birch bark triterpene extract from the outer bark of birch (TE) was obtained from Amryt AG, Niefern-Öschelbronn, Germany, comprising betulin 81.60%, lupeol 2.08%, betulinic acid 3.84%, erythrodiol 1.05%, oleanolic acid 0.97%, betulinic acid methyl ester 0.52%, and undisclosed substances 9.94%. Betulin was supplied by Sigma-Aldrich. Dimethyl sulfoxide (DMSO, laboratory reagent grade), dichloromethane (DCM, HPLC grade), and acetonitrile (HPLC gradient grade) were purchased from Fisher Scientific, UK.

Methods

Preparation of Polymer Solution

To prepare polymer solution for electrospun TE-free fibers, PLA was dissolved in a mixture of DCM and DMSO (4:1, v/v) with magnetic stirring at room temperature. The final concentration of PLA solution was 70 mg/mL.

To prepare a polymer solution for electrospun TE-loaded fibers, PLA and TE were separately dissolved in a mixture of DCM and DMSO (4:1, v/v) with magnetic stirring at room temperature. The solutions of PLA and TE were then mixed homogenously. The final concentration of PLA and TE in the mixed solution was 64 mg/mL and 4 mg/mL, respectively.

Electrospinning Process

A basic series electrospinning unit (Nanolab, Malaysia) was employed to prepare electrospun fibers. The polymer solution was placed in a 10-mL plastic syringe (Luer Lock Solo syringe, B Braun, Germany) pumped at a speed of 0.7 mL/h for electrospinning of TE-loaded fibers or 1.2 mL/h for electrospinning of TE-free fibers. The inner diameter of a blunt needle fixed on the syringe was 0.8 mm. A rotating drum collector was located 10 cm from the needle tip, covered with aluminum foil for deposition of fibers. Its rotation speed was adjusted to 1000 rpm. The voltage between the needle and the collector was set at 9 kV for TE-loaded fibers or 11 kV for TE-free fibers. The electrospinning experiments were performed at room temperature.

Scanning Electron Microscopy

The morphology of the electrospun fibers was analyzed by scanning electron microscopy (SEM) Zeiss DSM 940 A equipped with a Frame Grabber (Orion 5.25). The collected electrospun fiber films were cut into pieces (about 0.7 cm × 0.7 cm) and applied to a double-sided, conductive, and adhesive tape. The samples were covered with gold in a sputter coater (Bio Rad E5100) at 2.1 kV and 20 mA (4 × 60 s). The acceleration voltage was 5 kV.

To determine the average diameter as well as the diameter distribution of the optimal TE-free and TE-loaded electrospun fibers, 100 fibers were selected randomly from the SEM images with a magnification of 5000× and measured using image analysis software Image J (21).

Confocal Laser Scanning Microscopy

The fluorescence of TE was measured by fluorescence spectrophotometer in our preliminary experiment. The excitation wavelength and emission wavelength of TE were presented at 345 nm and 426 nm, respectively. Subsequently, confocal laser scanning microscopy (CLSM) (ZEISS LSM 880 with Airyscan, Germany) was employed to visualize the distribution of fluorescence originating from TE in the TE-loaded fibers, and TE-free fibers were used as contrast. TE-free fibers and TE-loaded fibers were separately fixed on microscope glass slides and examined directly at an excitation wavelength of 405 nm. Images in XY plane obtained from the surface of fibers were recorded and processed by the aid of ZEN 2.3 software.

Differential Scanning Calorimetry

Differential scanning calorimetry (DSC) analysis was performed by a DSC 820 calorimeter (Mettler-Toledo GmbH, Giessen, Germany). Samples of TE, PLA, TE-free fibers, and TE-loaded fibers were separately placed in 40-μL aluminum crucibles (Mettler-Toledo GmbH, Switzerland); an empty crucible was used as reference. The instrument was calibrated with indium from −94 to 490°C. An 80 mL/min nitrogen purging gas flow was used. Typically, after equilibration for 3 min at −10°C, the temperature was raised to 270°C, and then decreased to −10°C and raised to 270°C once more at a rate of 20 K/min.

X-ray Diffraction

X-ray diffraction (XRD) measurements of TE, PLA, TE-free fibers, and TE-loaded fibers were performed in a diffractometer (MiniFlex 600, Rigaku, Japan). The generator was operated at voltage of 40 kV and current of 15 mA. The spectrum was collected at a diffraction angle 2θ ranging from 0° to 90° with the step size 0.02° at the rate of 6°/min.

Dissolution Tests

About 2 mg of the TE-loaded fibers was weighted precisely and put in a plastic centrifugal tube. Subsequently, 10 mL dissolution medium were added. As TE is not sufficiently soluble in water and in order to maintain sink conditions, pH 7.4 phosphate buffered ethanol 60% (v/v) was used as dissolution medium (22). The tube was then shaken in an incubator (INFORS HT, Minitron, Switzerland) at a speed of 50 rpm at 32 ±1°C. One milliliter of the released medium was withdrawn at 0.5, 1, 2, 4, 6, 8, 24, 48, and 96 h, respectively, and replaced by fresh medium at the same volume and temperature. Finally, the fibers in medium were sonicated for 1.5 h to completely release TE from the samples. The dissolution tests were repeated in triplicate for the TE-loaded fibers.

High performance liquid chromatography (HPLC) (Shimadzu, Kyoto, Japan) method was used to measure the concentration of betulin (the main component of TE, which acts as an analytical marker) in the dissolution medium according to the previous report (23). Chromatographic separation was achieved on Nucleosil® C18 RP column (125 mm × 4 mm, Macherey-Nagel, Dueren, Germany) kept at 40°C. The mobile phase was composed of solvent A (0.1% phosphoric acid in water) and solvent B (acetonitrile). A gradient elution program was as follows: 0–13 min, 75% B; 14–18 min, a linear increase from 75 to 90% B; 19–35 min, 90% B; 36–40 min, a linear decrease from 90 to 75% B; and 41–45 min, 75% B. The flow rate was 1.2 mL/min, the volume of injection was 100 μL and the UV detection wavelength was 210 nm. A calibration curve of the peak area and known concentration of betulin was obtained (A = 45056 C + 8258.8, R2 = 0.9990).

RESULTS AND DISCUSSION

Preparation of Electrospun Fibers

To fabricate eletrospun fibers, PLA can be found to dissolve in single (24–26), binary (27–29), or ternary (12) solvent in literatures. Chloroform and DCM are the most frequently used solvents. They can be used alone (24,25) or mixed with other solvents, such as ethanol (27), tetrahydrofuran (28), and dimethylformamide (29). In this study, the raw PLA can be dissolved in chloroform, DCM, or hexafluoroisopropanol (HFIP). DCM was selected to prepare PLA solution considering it has lower toxicity than chloroform and it is more frequently used than HFIP. DMSO, an organic solvent with lower saturated vapor pressure and high boiling point, was added to DCM to prevent the blockage of spinneret needle caused by the quick evaporation of DCM when it was used alone. A similar phenomenon and method can also be found in preparing electrospun poly(butylene succinate) fibers (30).

The ratio of DCM and DMSO was investigated in our preliminary experiment. When the mixture of DCM and DMSO at ratio of 16:9 (v/v) was used to dissolve PLA, the electrospun TE-free PLA fibers presented splice-like welding from the SEM image (Fig. 1). The morphology of TE-free PLA fibers was greatly improved with the ratio of DCM and DMSO changed to 4:1 (v/v). The TE-loaded PLA fibers were then prepared by keeping the same ratio of the mixed solvents and slightly adjusting the voltage applied.

Fig. 1.

Fig. 1

Open in a new tab

SEM image of TE-free PLA electrospun fibers prepared by using mixed solvents of DCM and DMSO at ratio of 16:9 (v/v)

Morphology and Diameter

The SEM images of optimal TE-free and TE-loaded electrospun fibers are given in Fig. 2. Both of the fibers are randomly oriented. The TE-free fibers are more homogenous than TE-loaded fibers in which small amount of bead-like structure tends to occur. No signs are found that TE is deposited on the surface of TE-loaded fibers, indicating that TE is successfully entrapped within the matrix of PLA.

Fig. 2.

Fig. 2

Open in a new tab

SEM images and diameter distribution of TE-free (a, c) and TE-loaded (b, d) PLA electrospun fibers

SEM images revealed that the diameters of TE-free and TE-loaded fibers are within the range from 411 to 1615 nm. The average diameters of TE-free fibers is 980±238 nm and are in good accordance with published data where a diameter of PLA electrospun fibers of 894.6±292.3 nm was reported when a 6 % PLA solution was used (10). The average diameter of TE-loaded fibers (927±214 nm) was found to be slightly but not significantly smaller when compared to TE-free fibers. The diameter of electrospun fibers can be found to be decreased, increased, or unchanged after drug loading in literatures. For example, the entrapment of clarithromycin (at 5 wt%) decreased the diameter of blank PLA fibers from 1091.8±223.0 nm to 408.4±112.8 nm (31). The loading of dexamethasone (at 3.5 wt%) on electrospun fibers of PLA increased the diameter from 2.13±0.3 μm to 2.91±0.5 μm (32). The addition of cyclosporine A (10 wt%) did not influence the diameter of electrospun PLA fibers which could be kept in the range from 290 to 539 nm (33). The change of diameter is supposed to depend on the impact of drug to the polymer solution composites in the aspects of conductivity, viscosity, and surface tension (31). The average diameters of TE-free and TE-loaded fibers in this study are both within the diameter range of electrospun PLA fibers mentioned above.

Confocal Laser Scanning Microscopy

Examples of typical CLSM images of TE-free and TE-loaded electrospun fibers are shown in Fig. 3, where the fluorescent, bright-field, and merged images can be seen. The fluorescence intensity presented in TE-loaded fibers is much higher than that in TE-free fibers, especially in the fluorescent images at higher magnifications (180×). As the fluorescence detected represents TE, the result of CLSM confirms that TE was successfully loaded in the electrospun fibers of PLA.

Fig. 3.

Fig. 3

Open in a new tab

Examples of typical CLSM images of TE-free and TE-loaded PLA electrospun fibers at two magnifications: × 100 (a-f) and ×180 (g-h)

CLSM has been used to examine the core-shell morphology of electrospun fibers occasionally (34,35). Fluorescent agents were first added to polymer solution of the core and/or shell, and the location of fluorescence in the electrospun fibers was then observed by CLSM. Fluorescence microscope has also been employed to observe the loading of moxifloxacin (self-fluorescent) on Eudragit L100 electrospun fibers (36). In this study, CLSM is applied to prove the entrapment of TE in PLA electrospun fibers and no additional fluorescent agent is added because TE has fluorescent property itself.

Differential Scanning Calorimetry

A melting peak of TE is detected at approximately 252°C during the heating process (curve is shown in Fig. 4), which is in accordance with that of betulin in previous report (37,38). The result is reasonable because the main component of TE is betulin (18,20). As the peak of TE does not appear in the DSC thermograms of TE-loaded PLA fibers (Fig. 4), TE is supposed to disperse in PLA fibers as amorphous solid (39) or in a molecularly dispersed state.

Fig. 4.

Fig. 4

Open in a new tab

DSC pattern of TE, PLA, TE-free, and TE-loaded PLA electrospun fibers in the first (a) and PLA, TE-free, and TE-loaded PLA electrospun fibers in the second (b) heating process.

To eliminate the heating history of polymer, PLA, TE-free, and TE-loaded fibers underwent two heating processes (40). Fig. 4 shows the DSC pattern of PLA, TE-free, and TE-loaded fibers for the first and second heating process, respectively, and the corresponding glass transition temperature (Tg), cold crystallization temperature (Tc), and melting point (Tm) are displayed in Table 1. In the second heating scan, the DSC measurements reveals two endothermic peaks of PLA at 52.2°C and 173.0°C corresponding to Tg and Tm, respectively. The values are within the range of Tg (40–70°C) and Tm (130–230°C or typical 170–180°C) of PLA reported in literature (5,41). Moreover, the Tg is close to that of PLA Resomer 207 (same with PLA used in this study) in a previous report (42). As for TE-free and TE-loaded electrospun PLA fibers, the Tg are at 60.6°C and 60.1°C, and the Tm are at 177.3°C and 171.3°C, respectively. The measured values of Tg and Tm for electrospun TE-free fibers are higher than those of PLA, which has not been subjected to electrospinning. This is consistent with published data from Tsuji et al. (24). Obviously, dissolving PLA in a mixture of DCM and DMSO and subsequent evaporation of the solvent within an electrical field provokes a somewhat higher degree of order within the polymer. Tg and Tm values of TE-loaded fibers are slightly lower than those of TE-free fibers, which can be attributed to the intermolecular interaction between PLA and TE, indicating that TE acts as a kind of plasticizer for PLA. The same has been observed in electrospun drug-loaded PLA fibers (43) as well as Eudragit L100 fibers (36). The exothermic peaks of TE-free and TE-loaded fibers appearing near 121°C and 132°C separately belong to Tc of PLA, indicating the incomplete crystallization during the high-speed of electrospinning, while no such obvious peak is observed in the DSC curve of as-received PLA (44).

Table 1.

Glass Transition Temperature (Tg), Cold Crystallization Temperature (Tc) and Melting Point (Tm) of PLA, TE-free, and TE-loaded PLA Electrospun Fibers

The first heating process The second heating process
Tg (°C) Tc (°C) Tm (°C) Tg (°C) Tc (°C) Tm (°C)
PLA 72 196 52.2 173.0
TE-free fiber 66 81 179, 186 60.6 121 177.3
TE-loaded fiber 68 83 177 60.1 132 171.3
Open in a new tab

Diffraction pattern of TE, PLA, TE-free, and TE-loaded electrospun PLA fibers is shown in Fig. 5. The main peaks of TE at 2θ = 12.86°, 14.36°, and 18.96° are approaching to those of betulin, especially at 2θ = 12.37°, 14.31°, and 18.66° (37,45). In the pattern of TE-loaded electrospun PLA fibers, no peak of TE can be found. It is considered due to the low ratio of TE to PLA, the decreased crystallinity of TE, and the change of TE into amorphous state as described in a report of curcumin-loaded electrospun fibers (47). For the pristine PLA, peaks present at diffraction angles of 2θ = 17.08° and 19.31°, revealing the presence of crystalline phases, whereas TE-free and TE-loaded electrospun PLA fibers display very low intensity peaks at diffraction angles of 2θ = 16.57° and 16.47°, respectively, indicating a fewer degree in crystallinity or that the crystallite size is too small to be detected by XRD (47–49).

Fig. 5.

Fig. 5

Open in a new tab

XRD patterns of TE, PLA, TE-free, and TE-loaded electrospun PLA fibers. This symbol (*) represents PLA peaks. The inset shows the PLA peaks of TE-free and TE-loaded fibers

Dissolution Testing

The dissolution profile of TE-loaded PLA electrospinning fibers is given in Fig. 6. A substantial burst release can be observed at first followed by sustained release of the TE. The released profile is in good agreement with the results published for many drug-loaded electrospun fibers (50–52). More than 60% of TE released at 0.5 h. This burst release is within the range described in literature. It is higher than that of ciprofloxacin from electrospun fiber (50) but lower than that of itraconazole from electrospun fiber (53). In general, there are three major mechanisms of drug release from electrospun nanofiber PLA membranes: desorption, diffusion, and degradation (6). The biphasic manner of TE release is considered due to the initial desorption of drug from the outmost surface of fibers and subsequent diffusion-mediated release. The initial burst release of drug from electrospun fibers is reported to be desired for wound healing (51,52). The initial burst release of curcumin-loaded electrospun fibers is supposed to help in controlling early infection post orthopedic or shin surgery due to the effect of curcumin against biofilm of some bacteria (51). As TE also has an inhibitory effect on bacterial biofilms (54), the initial burst release of TE-loaded electrospun PLA fibers is thus potential to address the problem of early infection in wound healing. Additionally, the TE-loaded PLA fibers are hardly supposed to degrade within the period of dissolution tests referring to the report where in vitro degradation test was performed to a comparable PLA mesh (55), and the release mechanism of TE is considered not to be due to the degradation of PLA.

Fig. 6.

Fig. 6

Open in a new tab

Accumulative release of TE from TE-loaded PLA electrospun fibers

The most frequently used medium in dissolution tests of electrospun fibers is phosphate buffer solution (PBS) and sometimes organic solvent was added to PBS to facilitate the dissolution of drug when it is not readily to dissolve in water (56). In this study, ethanol was added to PBS to promote the release of TE. At 96 h, less than 8% of TE is not released from the PLA fibers, which is considered to be encapsulated deep inside the PLA fibers (50).

CONCLUSION

TE-loaded PLA fibers were successfully prepared by electrospinning technology. TE was confirmed to be entrapped in the PLA electrospun fibers by CLSM. Consequently, dissolution test showed a sustained release, however, with a marked burst release. DSC and XRD data revealed that TE was either dispersed in PLA as amorphous solid or in a molecularly dispersed state. More than 90% of TE was released in vitro from the electrospun fibers with an initial burst release. The TE-loaded electrospun PLA fibers in this study show promising potential for use as wound dressing.

Acknowledgements

The authors would like to thank the university level scholar exchanges fellowship between Peking University and University of Tübingen. The main work was finished in Tübingen.

Funding

Open Access funding enabled and organized by Projekt DEAL.

Declarations

Conflicts of Interest

The authors declare no competing interests.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Ambekar RS, Kandasubramanian B. Advancements in nanofibers for wound dressing: a review. Eur Polym J. 2019;117:304–336.
  • 2.Mwiiri FK, Daniels R. Chapter 3 - Electrospun nanofibers for biomedical applications. In: Shegokar R, editor. Delivery of drugs. Amsterdam: Elsevier; 2020. pp. 53–74. [Google Scholar]
  • 3.Chen S, Liu B, Carlson MA, Gombart AF, Reilly DA, Xie J. Recent advances in electrospun nanofibers for wound healing. Nanomedicine (London) 2017;12:1335–1352. doi: 10.2217/nnm-2017-0017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Miguel SP, Sequeira RS, Moreira AF, Cabral C, Mendonca AG, Ferreira P, et al. An overview of electrospun membranes loaded with bioactive molecules for improving the wound healing process. Eur J Pharm Biopharm. 2019;139:1–22. [DOI] [PubMed]
  • 5.Ranjith R, Balraj S, Ganesh J, John Milton MC. Therapeutic agents loaded chitosan-based nanofibrous mats as potential wound dressings: A review. Mater Today Chem. 2019;12:386–395. doi: 10.1016/j.mtchem.2019.03.008. [DOI] [Google Scholar]
  • 6.Farah S, Anderson DG, Langer R. Physical and mechanical properties of PLA, and their functions in widespread applications - A comprehensive review. Adv Drug Deliv Rev. 2016;107:367–392. doi: 10.1016/j.addr.2016.06.012. [DOI] [PubMed] [Google Scholar]
  • 7.Santoro M, Shah SR, Walker JL, Mikos AG. Poly(lactic acid) nanofibrous scaffolds for tissue engineering. Adv Drug Deliv Rev. 2016;107:206–212. doi: 10.1016/j.addr.2016.04.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Toncheva A, Spasova M, Paneva D, Manolova N, Rashkov I. Polylactide (PLA)-based electrospun fibrous materials containing ionic drugs as wound dressing materials: a review. Int J Polym Mater Po. 2013;63:657–671. doi: 10.1080/00914037.2013.854240. [DOI] [Google Scholar]
  • 9.Murariu M, Dubois P. PLA composites: From production to properties. Adv Drug Deliv Rev. 2016;107:17–46. doi: 10.1016/j.addr.2016.04.003. [DOI] [PubMed] [Google Scholar]
  • 10.Maleki H, Semnani Rahbar R, Nazir A. Improvement of physical and mechanical properties of electrospun poly(lactic acid) nanofibrous structures. Iran Polym J. 2020;29:841–851. doi: 10.1007/s13726-020-00844-2. [DOI] [Google Scholar]
  • 11.Bi H, Feng T, Li B, Han Y. In vitro and in vivo comparison study of electrospun PLA and PLA/PVA/SA fiber membranes for wound healing. Polymers (Basel) 2020;12:839. doi: 10.3390/polym12040839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Sharma K, Bullock A, Ralston D, MacNeil S. Development of a one-step approach for the reconstruction of full thickness skin defects using minced split thickness skin grafts and biodegradable synthetic scaffolds as a dermal substitute. Burns. 2014;40:957–965. doi: 10.1016/j.burns.2013.09.026. [DOI] [PubMed] [Google Scholar]
  • 13.Cejkova J, Cejka C, Trosan P, Zajicova A, Sykova E, Holan V. Treatment of alkali-injured cornea by cyclosporine A-loaded electrospun nanofibers - an alternative mode of therapy. Exp Eye Res. 2016;147:128–137. doi: 10.1016/j.exer.2016.04.016. [DOI] [PubMed] [Google Scholar]
  • 14.Ren X, Han Y, Wang J, Jiang Y, Yi Z, Xu H, et al. An aligned porous electrospun fibrous membrane with controlled drug delivery - an efficient strategy to accelerate diabetic wound healing with improved angiogenesis. Acta Biomater. 2018;70:140–53. [DOI] [PubMed]
  • 15.Zhao R, Li X, Sun B, Tong Y, Jiang Z, Wang C. Nitrofurazone-loaded electrospun PLLA/sericin based dual-layer fiber mats for wound dressing applications. RSC Adv. 2015;5:16940–16949. doi: 10.1039/C4RA16208K. [DOI] [Google Scholar]
  • 16.Kobsa S, Kristofik NJ, Sawyer AJ, Bothwell AL, Kyriakides TR, Saltzman WM. An electrospun scaffold integrating nucleic acid delivery for treatment of full-thickness wounds. Biomaterials. 2013;34:3891–3901. doi: 10.1016/j.biomaterials.2013.02.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Krasutsky PA. Birch bark research and development. Nat Prod Rep. 2006;23:919–942. doi: 10.1039/b606816b. [DOI] [PubMed] [Google Scholar]
  • 18.Amiri S, Dastghaib S, Ahmadi M, Mehrbod P, Khadem F, Behrouj H, et al. Betulin and its derivatives as novel compounds with different pharmacological effects. Biotechnol Adv. 2020;38:107409. [DOI] [PubMed]
  • 19.Scheffler A. The wound healing properties of betulin from birch bark from bench to bedside. Planta Med. 2019;85:524–527. doi: 10.1055/a-0850-0224. [DOI] [PubMed] [Google Scholar]
  • 20.Ebeling S, Naumann K, Pollok S, Wardecki T, Vidal-Y-Sy S, Nascimento JM, et al. From a traditional medicinal plant to a rational drug: understanding the clinically proven wound healing efficacy of birch bark extract. PLoS One. 2014;9:e86147. [DOI] [PMC free article] [PubMed]
  • 21.Frew Q, Rennekampff HO, Dziewulski P, Moiemen N, BBW-11 Study Group, Zahn T, et al. Betulin wound gel accelerated healing of superficial partial thickness burns: results of a randomized, intra-individually controlled, phase III trial with 12-months follow-up. Burns. 2019;45:876–90. [DOI] [PubMed]
  • 22.Paaver U, Heinamaki J, Laidmae I, Lust A, Kozlova J, Sillaste E, et al. Electrospun nanofibers as a potential controlled-release solid dispersion system for poorly water-soluble drugs. Int J Pharm. 2015;479:252–60. [DOI] [PubMed]
  • 23.Mwiiri FK, Brandner JM, Daniels R. Electrospun bioactive wound dressing containing colloidal dispersions of birch bark dry extract. Pharmaceutics. 2020;12:770–789. doi: 10.3390/pharmaceutics12080770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Armbruster M, Moenckedieck M, Scherliess R, Daniels R, Wahl MA. Birch bark dry extract by supercritical fluid technology: extract characterisation and use for stabilisation of semisolid systems. Appl Sci (Basel) 2017;7:292–305. doi: 10.3390/app7030292. [DOI] [Google Scholar]
  • 25.Tsuji H, Nakano M, Hashimoto M, Takashima K, Katsura S, Mizuno A. Electrospinning of poly(lactic acid) stereocomplex nanofibers. Biomacromolecules. 2006;7:3316–3320. doi: 10.1021/bm060786e. [DOI] [PubMed] [Google Scholar]
  • 26.Schofer MD, Roessler PP, Schaefer J, Theisen C, Schlimme S, Heverhagen JT, et al. Electrospun PLLA nanofiber scaffolds and their use in combination with BMP-2 for reconstruction of bone defects. PLoS One. 2011;6:e25462. [DOI] [PMC free article] [PubMed]
  • 27.Kurpinski KT, Stephenson JT, Janairo RR, Lee H, Li S. The effect of fiber alignment and heparin coating on cell infiltration into nanofibrous PLLA scaffolds. Biomaterials. 2010;31:3536–3542. doi: 10.1016/j.biomaterials.2010.01.062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Shen W, Zhang G, Ge X, Li Y, Fan G. Effect on electrospun fibers by synthesis of high branching polylactic acid. R Soc Open Sci. 2018;5:180134. doi: 10.1098/rsos.180134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Matschegewski C, Matthies J, Grabow N, Schmitz K. Cell adhesion and viability of human endothelial cells on electrospun polymer scaffolds. Current Directions in Biomedical Engineering. 2016;2:11–14. doi: 10.1515/cdbme-2016-0006. [DOI] [Google Scholar]
  • 30.Zong XH, Kim K, Fang DF, Ran SF, Hsiao BS, Chu B. Structure and process relationship of electrospun bioabsorbable nanofiber membranes. Polymer. 2002;43:4403–4412. doi: 10.1016/S0032-3861(02)00275-6. [DOI] [Google Scholar]
  • 31.Cooper CJ, Mohanty AK, Misra M. Electrospinning process and structure relationship of biobased poly(butylene succinate) for nanoporous fibers. ACS Omega. 2018;3:5547–5557. doi: 10.1021/acsomega.8b00332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Wei A, Wang, Wang X, Wei Q, Ge M, Hou D. Preparation and characterization of the electrospun nanofibers loaded with clarithromycin. J Appl Polym Sci. 2010;118:346–352. doi: 10.1002/app.32363. [DOI] [Google Scholar]
  • 33.Alves PE, Soares BG, Lins LC, Livi S, Santos EP. Controlled delivery of dexamethasone and betamethasone from PLA electrospun fibers: A comparative study. Eur Polym J. 2019;117:1–9. doi: 10.1016/j.eurpolymj.2019.05.001. [DOI] [Google Scholar]
  • 34.Holan V, Chudickova M, Trosan P, Svobodova E, Krulova M, Kubinova S, et al. Cyclosporine A-loaded and stem cell-seeded electrospun nanofibers for cell-based therapy and local immunosuppression. J Control Release. 2011;156:406–12. [DOI] [PubMed]
  • 35.Aytac Z, Uyar T. Core-shell nanofibers of curcumin/cyclodextrin inclusion complex and polylactic acid: Enhanced water solubility and slow release of curcumin. Int J Pharm. 2017;518:177–184. doi: 10.1016/j.ijpharm.2016.12.061. [DOI] [PubMed] [Google Scholar]
  • 36.Fang Y, Zhu X, Wang N, Zhang X, Yang D, Nie J, et al. Biodegradable core-shell electrospun nanofibers based on PLA and γ-PGA for wound healing. Eur Polym J. 2019;116:30–7.
  • 37.Giram PS, Shitole A, Nande SS, Sharma N, Garnaik B. Fast dissolving moxifloxacin hydrochloride antibiotic drug from electrospun Eudragit L-100 nonwoven nanofibrous mats. Mater Sci Eng C Mater Biol Appl. 2018;92:526–539. doi: 10.1016/j.msec.2018.06.031. [DOI] [PubMed] [Google Scholar]
  • 38.Zhao X, Wang W, Zu Y, Zhang Y, Li Y, Sun W, et al. Preparation and characterization of betulin nanoparticles for oral hypoglycemic drug by antisolvent precipitation. Drug Deliv (Lond). 2014;21:467–79. [DOI] [PubMed]
  • 39.Okada M, Suzuki K, Mawatari Y, Tabata M. Biopolyester prepared using unsaturated betulin (betulinol) extracted from outer birch bark and dicarboxylic acid dichlorides and its thermal-induced crosslinking. Eur Polym J. 2019;113:12–17. doi: 10.1016/j.eurpolymj.2019.01.038. [DOI] [Google Scholar]
  • 40.Kontogiannopoulos KN, Assimopoulou AN, Tsivintzelis I, Panayiotou C, Papageorgiou VP. Electrospun fiber mats containing shikonin and derivatives with potential biomedical applications. Int J Pharm. 2011;409:216–228. doi: 10.1016/j.ijpharm.2011.02.004. [DOI] [PubMed] [Google Scholar]
  • 41.Wang Y, Qian J, Liu T, Xu W, Zhao N, Suo A. Electrospun PBLG/PLA nanofiber membrane for constructing in vitro 3D model of melanoma. Mater Sci Eng C Mater Biol Appl. 2017;76:313–318. doi: 10.1016/j.msec.2017.03.098. [DOI] [PubMed] [Google Scholar]
  • 42.Jamshidian M, Tehrany EA, Imran M, Jacquot M, Desobry S. Poly-lactic acid: production, applications, nanocomposites, and release studies. Compr Rev Food Sci Food Saf. 2010;9:552–571. doi: 10.1111/j.1541-4337.2010.00126.x. [DOI] [PubMed] [Google Scholar]
  • 43.Coullerez G, Lowe C, Pechy P, Kausch HH, Hilborn J. Synthesis of acrylate functional telechelic poly(lactic acid) oligomer by transesterification. J Mater Sci Mater Med. 2000;11:505–510. doi: 10.1023/A:1008948325177. [DOI] [PubMed] [Google Scholar]
  • 44.Wongkanya R, Teeranachaideekul V, Makarasen A, Chuysinuan P, Yingyuad P, Nooeaid P, et al. Electrospun poly(lactic acid) nanofiber mats for controlled transdermal delivery of essential oil from Zingiber cassumunar Roxb. Mater Res Express. 2020;7:055305.
  • 45.Liu Y, Wei H, Wang Z, Li Q, Tian N. Simultaneous enhancement of strength and toughness of PLA induced by miscibility variation with PVA. Polymers (Basel) 2018;10:1178.42. doi: 10.3390/polym10101178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Shakhtshneider TP, Mikhailenko MA, Drebushchak VA, Drebushchak TN, Malyar YN, Kuznetsova SA. Effect of ball-milling on the formation of betulin and betulin diacetate composites with polyethylene glycol. Mater Today Proc. 2019;12:78–81. doi: 10.1016/j.matpr.2019.03.068. [DOI] [Google Scholar]
  • 47.Wang F, Sun Z, Yin J, Xu L. Preparation, characterization and properties of porous PLA/PEG/curcumin composite nanofibers for antibacterial application. Nanomaterials (Basel) 2019;9:508. doi: 10.3390/nano9040508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Septiyanti M, Septevani AA, Ghozali M, Fahmiati S, Triwulandari E, Restu WK, et al. Effect of solvent combination on electrospun stereocomplex polylactic acid nanofiber properties. Macromol Symp. 2020;391:1900134.
  • 49.Gómez-Pachón EY, Vera-Graziano R, Campos RM. Structure of poly(lactic-acid) PLA nanofibers scaffolds prepared by electrospinning. The International Congress of Mechanical Engineering and Agricultural Sciences 2013, IOP Conference Serie. Materials Science and Engineering, Mexico. 2014;59:12003. [Google Scholar]
  • 50.Nonato RC, Mei LHI, Bonse BC, Chinaglia EF, Morales AR. Nanocomposites of PLA containing ZnO nanofibers made by solvent cast 3D printing: production and characterization. Eur Polym J. 2019;114:271–278. doi: 10.1016/j.eurpolymj.2019.02.026. [DOI] [Google Scholar]
  • 51.Li H, Williams GR, Wu J, Lv Y, Sun X, Wu H, et al. Thermosensitive nanofibers loaded with ciprofloxacin as antibacterial wound dressing materials. Int J Pharm. 2017;517:135–47. [DOI] [PubMed]
  • 52.Perumal G, Pappuru S, Chakraborty D, Maya NA, Chand DK, Doble M. Synthesis and characterization of curcumin loaded PLA-hyperbranched polyglycerol electrospun blend for wound dressing applications. Mater Sci Eng C Mater Biol Appl. 2017;76:1196–1204. doi: 10.1016/j.msec.2017.03.200. [DOI] [PubMed] [Google Scholar]
  • 53.Ajmal G, Bonde GV, Thokala S, Mittal P, Khan G, Singh J, et al. Ciprofloxacin HCl and quercetin functionalized electrospun nanofiber membrane: fabrication and its evaluation in full thickness wound healing. Artif Cells Nanomed Biotechnol. 2019;47:228–40. [DOI] [PubMed]
  • 54.Nagy ZK, Balogh A, Demuth B, Pataki H, Vigh T, Szabo B, et al. High speed electrospinning for scaled-up production of amorphous solid dispersion of itraconazole. Int J Pharm. 2015;480:137–42. [DOI] [PubMed]
  • 55.Rajkumari J, Borkotoky S, Murali A, Suchiang K, Mohanty SK, Busi S. Attenuation of quorum sensing controlled virulence factors and biofilm formation in Pseudomonas aeruginosa by pentacyclic triterpenes, betulin and betulinic acid. Microb Pathog. 2018;118:48–60. doi: 10.1016/j.micpath.2018.03.012. [DOI] [PubMed] [Google Scholar]
  • 56.de Tayrac R, Chentouf S, Garreau H, Braud C, Guiraud I, Boudeville P, et al. In vitro degradation and in vivo biocompatibility of poly(lactic acid) mesh for soft tissue reinforcement in vaginal surgery. J Biomed Mater Res B Appl Biomater. 2008;85:529–36. [DOI] [PubMed]
  • 57.Suwantong O, Ruktanonchai U, Supaphol P. Electrospun cellulose acetate fiber mats containing asiaticoside or Centella asiatica crude extract and the release characteristics of asiaticoside. Polymer. 2008;49:4239–4247. doi: 10.1016/j.polymer.2008.07.020. [DOI] [Google Scholar]

Articles from AAPS PharmSciTech are provided here courtesy of Springer

RESOURCES